114 studies found for:    "Idiopathic thrombocytopenic purpura"
Show Display Options
Rank Status Study
1 Completed Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Immune Thrombocytopenic Purpura
Intervention: Biological: Inactivated Trivalent Influenza vaccine
2 Completed Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura (ITP);   Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: rituximab
3 Completed Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
Condition: Idiopathic Thrombocytopenic Purpura
Intervention:
4 Not yet recruiting MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP
Conditions: Immune Thrombocytopenic Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Biological: Blisibimod;   Other: Placebo
5 Completed Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
6 Completed Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Anti-D
7 Completed Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Helicobacter Pylori Infection
Intervention: Drug: lansoprazole, clarithromycin, amoxycillin
8 Completed Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Placebo;   Drug: AKR-501 Tablets
9 Completed
Has Results
A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Intervention: Biological: Gammaplex, intravenous immunoglobulin
10 Completed
Has Results
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Eltrombopag oral tablets
11 Unknown  Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
Condition: Acute Idiopathic Thrombocytopenic Purpura
Intervention:
12 Completed
Has Results
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: SB-497115-GR 12.5mg;   Drug: SB-497115-GR 25mg;   Drug: SB-497115-GR 12.5mg matching placebo;   Drug: SB-497115-GR 50 mg
13 Completed Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: PG2
14 Completed Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: AMG 531
15 Completed A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rituximab
16 Completed Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Octagam 10%
17 Completed A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rituximab [MabThera/Rituxan]
18 Terminated Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Biological: GMA161
19 Active, not recruiting The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Dexamethasone;   Drug: Dexamethasone and Rituximab
20 Terminated A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Eltrombopag;   Drug: E5501 - Avatrombopag maleate

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years